173 related articles for article (PubMed ID: 37648713)
61. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
62. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
[TBL] [Abstract][Full Text] [Related]
63. Circulating microRNA-92a-3p in colorectal cancer: a review.
Yamada NO; Senda T
Med Mol Morphol; 2021 Sep; 54(3):193-202. PubMed ID: 33620640
[TBL] [Abstract][Full Text] [Related]
64. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
65. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
[TBL] [Abstract][Full Text] [Related]
66. Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
Pichler M; Winter E; Stotz M; Eberhard K; Samonigg H; Lax S; Hoefler G
Br J Cancer; 2012 May; 106(11):1826-32. PubMed ID: 22549179
[TBL] [Abstract][Full Text] [Related]
67. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
68. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma.
Kara M; Yumrutas O; Ozcan O; Celik OI; Bozgeyik E; Bozgeyik I; Tasdemir S
Gene; 2015 Aug; 567(1):81-6. PubMed ID: 25925209
[TBL] [Abstract][Full Text] [Related]
69. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
[TBL] [Abstract][Full Text] [Related]
70. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
71. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.
Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R
Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.
Fang L; Li H; Wang L; Hu J; Jin T; Wang J; Yang BB
Oncotarget; 2014 May; 5(10):2974-87. PubMed ID: 24912422
[TBL] [Abstract][Full Text] [Related]
73. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
74. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N
J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419
[TBL] [Abstract][Full Text] [Related]
75. Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer.
Gherman A; Balacescu L; Popa C; Cainap C; Vlad C; Cainap SS; Balacescu O
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445798
[TBL] [Abstract][Full Text] [Related]
76. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.
Ren LL; Yan TT; Shen CQ; Tang JY; Kong X; Wang YC; Chen J; Liu Q; He J; Zhong M; Chen HY; Hong J; Fang JY
Cell Death Dis; 2018 Jun; 9(6):687. PubMed ID: 29880874
[TBL] [Abstract][Full Text] [Related]
77. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.
Thomaidis T; Maderer A; Formentini A; Bauer S; Trautmann M; Schwarz M; Neumann W; Kittner JM; Schad A; Link KH; Rey JW; Weinmann A; Hoffman A; Galle PR; Kornmann M; Moehler M
J Exp Clin Cancer Res; 2014 Oct; 33(1):83. PubMed ID: 25272957
[TBL] [Abstract][Full Text] [Related]
78. LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer.
Yao F; Huang X; Xie Z; Chen J; Zhang L; Wang Q; Long H; Jiang J; Wu Q
Carcinogenesis; 2022 Oct; 43(9):895-907. PubMed ID: 35914269
[TBL] [Abstract][Full Text] [Related]
79. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract][Full Text] [Related]
80. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
